Hemoglobin
Hemoglobin is the iron-containing protein in red blood cells that carries oxygen from the lungs to tissues and returns carbon dioxide for exhalation. Low levels suggest anemia from iron deficiency, blood loss, or chronic disease, while high levels may indicate dehydration, smoking, or polycythemia. Standard marker on every complete blood count.
Units: g/dL; some labs report g/L (g/L = g/dL × 10). Check the units on your report before comparing to any range here.
Optimal range: who says what
Institutions, researchers and practitioners draw the line in different places. Each position is listed with who holds it and, where a document states it, a link. How we verify ranges.
- Institution or study1-3 g/dL above the WHO threshold (lowest mortality)UK cohort of 502,188 adults (Ahmad et al. 2026, Ann Intern Med)The study used the WHO anaemia thresholds (13.0 g/dL men, 12.0 g/dL women), so this is about 14-16 g/dL for men and 13-15 g/dL for women. The curve was U-shaped: 10-year mortality was 12.5% more than 2 g/dL below the threshold vs 4.5% in the reference group
- Institution or study14-17 g/dL (men)Cohort of 17,030 community-dwelling adults 66 and older (Culleton et al. 2006, Blood)Lowest all-cause mortality in older men; the authors suggest redefining normal hemoglobin in the elderly
- Institution or study13-15 g/dL (women)Cohort of 17,030 community-dwelling adults 66 and older (Culleton et al. 2006, Blood)Lowest all-cause mortality in older women; the authors suggest redefining normal hemoglobin in the elderly
- Published reference interval12-16 g/dL (women), 13-18 g/dL (men)Cleveland Clinic
- Lab reference intervalMen: 13.5-17.5 g/dL, Women: 12.0-15.5 g/dLWhat a lab report flags against. A lab interval is not an optimal target.
21 of 21 itemized panels
Complete Blood Count (CBC)
What is Hemoglobin?
Hemoglobin (Hgb or Hb) is the iron-containing protein in red blood cells responsible for transporting oxygen from your lungs to tissues and carbon dioxide back to lungs for exhalation. Each red blood cell contains about 270 million hemoglobin molecules. Normal hemoglobin levels are 13.5-17.5 g/dL in men and 12.0-15.5 g/dL in women.
Hemoglobin consists of four protein subunits (globin chains) each containing a heme group with an iron atom that binds oxygen. The hemoglobin molecule can carry four oxygen molecules simultaneously. Hemoglobin concentration is the primary criterion for diagnosing anemia (low hemoglobin) and polycythemia (high hemoglobin). Unlike RBC count which measures cell numbers, hemoglobin directly reflects oxygen-carrying capacity.
Hemoglobin is produced in bone marrow and requires iron, vitamin B12, folate, and protein. Each hemoglobin molecule lives 120 days within the RBC. Low hemoglobin causes fatigue, shortness of breath, and reduced exercise tolerance due to inadequate oxygen delivery. High hemoglobin increases blood viscosity and thrombosis risk. Hemoglobin is the single most important parameter from a CBC for assessing overall health and oxygen delivery.
Why Hemoglobin Is the Gold Standard for Oxygen Status
- Defines anemia: WHO criteria—hemoglobin <13 g/dL (men) or <12 g/dL (women) regardless of RBC count or hematocrit
- Oxygen delivery: Directly reflects blood's oxygen-carrying capacity. Each 1 g/dL drop reduces oxygen delivery by ~7%
- Transfusion decisions: Hemoglobin <7-8 g/dL typically requires blood transfusion, especially if symptomatic
- Surgical risk: Low hemoglobin increases perioperative morbidity and mortality. Often corrected before elective surgery
- Athletic performance: Hemoglobin 14-16 g/dL optimal for endurance athletes. Lower levels impair VO2 max and performance
- Cardiovascular stress: Low hemoglobin forces heart to work harder (increased cardiac output), worsening heart failure and ischemia
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: Relations of Anemia With the All-Cause Mortality and Cardiovascular Mortality in General Population: A Meta-Analysis (Liu et al., 2019); Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention (Kwok et al., 2016); A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study (Zakai et al., 2005). No single paper sets these cutoffs; for attributed targets see who says what.
OptimalMen: 14.5-16.5 g/dL, Women: 13.0-15.0 g/dL▼
- Ideal range for oxygen delivery, energy levels, and cardiovascular health
- Athletes often target upper end of this range
- Provides adequate oxygen for peak physical and cognitive performance without excessive blood viscosity
Borderline LowMen: 12.0-14.5 g/dL, Women: 11.0-13.0 g/dL▼
- Mild anemia or iron deficiency
- May cause fatigue, reduced exercise capacity
- Check ferritin, iron studies, B12, folate
- Treat underlying cause
- Athletes with hemoglobin in this range will have impaired performance
Moderate Anemia8.0-12.0 g/dL▼
- Moderate anemia causing symptoms (fatigue, dyspnea, tachycardia)
- Requires investigation and treatment
- Check MCV, iron studies, B12, folate, reticulocyte count
- Transfusion generally not needed unless symptomatic or actively bleeding
- Treat underlying cause aggressively
Severe Anemia or Polycythemia<8.0 g/dL or >18.0 g/dL▼
- <8 g/dL: Severe anemia
- Transfusion typically indicated, especially if symptomatic, unstable, or bleeding
- Urgent investigation for cause
- >18 g/dL: Severe polycythemia
- High thrombosis risk
- Urgent phlebotomy and investigation for polycythemia vera or secondary causes
- Relations of Anemia With the All-Cause Mortality and Cardiovascular Mortality in General Population: A Meta-Analysis.
- Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention.
- A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study.
What raises or lowers Hemoglobin
Causes of high Hemoglobin
- Polycythemia vera: JAK2 mutation-driven bone marrow disorder producing excess RBCs
- Secondary polycythemia: Chronic hypoxia (lung disease, sleep apnea, smoking, high altitude), kidney tumors, EPO-secreting tumors
- Dehydration: Relative polycythemia from volume loss
- Testosterone use: Stimulates EPO production
- Genetic: Congenital polycythemia from EPO receptor mutations (rare)
Causes of low Hemoglobin
- Blood loss: Acute (trauma, GI bleeding, surgery) or chronic (menstruation, occult GI bleeding)
- Iron deficiency: Most common cause worldwide. From blood loss, inadequate intake, malabsorption
- Vitamin deficiency: B12 or folate deficiency (macrocytic anemia)
- Chronic disease: Inflammation, cancer, chronic kidney disease, rheumatoid arthritis, IBD
- Bone marrow disorders: Aplastic anemia, myelodysplastic syndrome, leukemia
- Hemolytic anemia: Autoimmune, G6PD deficiency, sickle cell, hereditary spherocytosis
- Medications: Chemotherapy, some antibiotics, NSAIDs (GI bleeding)
- Genetic: Thalassemia, sickle cell disease
Symptoms when Hemoglobin is high or low
When high
Symptoms of high hemoglobin (polycythemia):
- Headaches, dizziness, tinnitus
- Blurred vision or visual disturbances
- Facial flushing (plethora)
- Itching after bathing (aquagenic pruritus)
- Easy bruising or bleeding
- Thrombosis: DVT, PE, stroke, MI (most serious complication)
Very high hemoglobin makes blood thicker, which raises the risk of clots. Untreated polycythemia vera carries a high risk of thrombosis.
When low
- Fatigue and weakness: Most common, progressive with worsening anemia
- Shortness of breath: Initially with exertion, at rest if severe (<8 g/dL)
- Pale skin and conjunctiva: Noticeable when hemoglobin <10 g/dL
- Rapid or irregular heartbeat: Compensatory tachycardia
- Dizziness and lightheadedness: Especially orthostatic (when standing)
- Chest pain: Demand ischemia if coronary disease present
- Cold hands and feet: Reduced oxygen delivery to extremities
- Headaches and difficulty concentrating: Brain oxygen deprivation
- Pica: Craving ice or non-food items (iron deficiency specific)
Symptom severity correlates with hemoglobin level and rapidity of decline. Chronic anemia (hemoglobin 9-10 g/dL) may be well-tolerated with minimal symptoms due to physiologic compensation. Acute drop to same level causes severe symptoms.
How to move Hemoglobin
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Iron Repletion for Iron Deficiency Anemia
- Oral iron: Ferrous sulfate 325 mg (65 mg elemental iron) 2-3 times daily on empty stomach. Vitamin C enhances absorption. Hemoglobin should increase 1-2 g/dL per month
- IV iron: If oral not tolerated, malabsorption, or need rapid repletion. Iron sucrose, ferric carboxymaltose, iron dextran. Hemoglobin rises within 2-4 weeks
- Dietary iron: Red meat (heme iron, best absorbed), spinach, lentils, fortified cereals. Pair with vitamin C
- Investigate blood loss: GI endoscopy if unexplained iron deficiency. Treat menorrhagia if heavy periods cause
- Duration: Continue iron 3-6 months after hemoglobin normalizes to replenish stores (recheck ferritin)
B12 and Folate Replacement
- B12 deficiency (high MCV): B12 1000 mcg IM weekly for 4-8 weeks, then monthly lifelong. Or oral B12 1000-2000 mcg daily. Hemoglobin improves in 1-2 months
- Folate deficiency: Folic acid 1-5 mg daily. Hemoglobin normalizes in 4-8 weeks. Common in pregnancy, alcoholism, malabsorption
- Address cause: Pernicious anemia (autoimmune), gastric bypass, vegan diet (B12), alcoholism (folate), medications (methotrexate depletes folate)
- Don't miss B12: Always check B12 before treating with folate alone—folate can mask B12 deficiency while nerve damage progresses
Manage Anemia of Chronic Disease
- Treat underlying condition: Inflammatory bowel disease, rheumatoid arthritis, cancer, chronic kidney disease
- Erythropoietin-stimulating agents (ESAs): If hemoglobin <10 g/dL from chronic kidney disease or chemotherapy. Epoetin alfa or darbepoetin. Your clinician sets a partial-correction hemoglobin target; pushing higher raises thrombosis risk
- Iron supplementation: IV iron often needed with ESAs. Functional iron deficiency common in chronic disease despite normal ferritin
- Anti-inflammatory therapy: Reduce cytokines (IL-6, TNF-alpha) that suppress EPO and iron utilization
- Transfusion: If hemoglobin <7-8 g/dL and symptomatic, transfusion is considered
Treat Polycythemia
- Polycythemia vera: Phlebotomy to the hematocrit target your hematologist sets (the hematocrit page covers the CYTO-PV trial target). Aspirin 81 mg daily. Hydroxyurea if high risk
- Secondary polycythemia: Treat cause (CPAP for sleep apnea, smoking cessation, oxygen for lung disease). Phlebotomy if hemoglobin >18 g/dL and symptomatic
- Dehydration: Rehydrate with 2-3 liters fluids. Recheck after hydration—should normalize if relative polycythemia
- Testosterone-induced: Reduce dose or stop. Monitor hemoglobin every 3 months on testosterone therapy
Optimize Hemoglobin for Performance and Health
- Maintain iron stores: Check ferritin and supplement if low to support hemoglobin production
- Altitude training: Living/training at altitude increases hemoglobin. Athletes use this to enhance oxygen capacity
- Adequate protein: 1.0-1.2 g/kg daily provides amino acids for globin chains
- Optimize EPO production: Adequate sleep (EPO produced during sleep), avoid chronic kidney disease, treat sleep apnea
- Blood doping (illegal): EPO injections or blood transfusions artificially increase hemoglobin. Banned in sports due to health risks and unfair advantage
When to retest
- After starting iron: Recheck hemoglobin in 4 weeks. Should increase 1-2 g/dL per month. If no response, consider IV iron or alternative diagnosis
- After B12/folate treatment: Recheck in 4-8 weeks. Reticulocytosis (increased reticulocytes) occurs within 3-7 days, confirming response
- Severe anemia (<7 g/dL): Monitor daily if hospitalized, every 1-2 weeks outpatient until stable
- After transfusion: Check hemoglobin 15 minutes post-transfusion. Each unit should increase hemoglobin by ~1 g/dL
- Chronic disease: Monitor every 3-6 months. Consider ESAs if persistent anemia despite treating underlying condition
- Polycythemia: Check every 1-3 months during phlebotomy treatment until stable, then every 3-6 months
- Annual screening: Healthy adults should have hemoglobin checked annually as part of routine CBC
Scientific Evidence
Anemia and Mortality
A meta-analysis of 15 studies found anemia associated with higher all-cause mortality (HR 1.41) and cardiovascular mortality (HR 1.33) in the general population, regardless of sex, age or history of cardiovascular disease.
Transfusion Thresholds
In 838 critically ill patients, transfusing only below 7 g/dL gave 30-day mortality similar to transfusing below 10 g/dL (18.7% vs 23.3%), and lower mortality in less acutely ill and younger patients. Patients with acute myocardial infarction or unstable angina were a possible exception.
Iron Deficiency Anemia Workup
British guidance: iron deficiency anaemia affects 2-5% of adult men and postmenopausal women in the developed world. Serum ferritin is the most powerful test for iron deficiency. All patients should get iron to correct anaemia and refill stores, and upper and lower gastrointestinal investigation should be considered in men and postmenopausal women.
Source: Guidelines for the management of iron deficiency anaemia.
Which Providers Test Hemoglobin?
Cheapest: Oura Health Panels at $99/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
21 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $99 | 50 | $1.98 | |
| $190 | 100+ | $1.90 | |
| $250 | 65 | $3.85 | |
| $297 | 100+ | $2.97 | |
 Labcorp OnDemand | $338 | 50+ | $6.76 |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $829 | 54 | $15.35 | |
| $895 | 100+ | $8.95 | |
| $996 | 59 | $16.88 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer Hemoglobin. Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Experts discussing Hemoglobin
Podcast episodes where clinicians and researchers cover this marker in depth. Curated by hand; an episode is listed only when the marker is a substantial topic, not a passing mention.
Frequently Asked Questions
What is the optimal range for Hemoglobin?
Published positions differ: 1-3 g/dL above the WHO threshold (lowest mortality) (UK cohort of 502,188 adults (Ahmad et al. 2026, Ann Intern Med)); 14-17 g/dL (men) (Cohort of 17,030 community-dwelling adults 66 and older (Culleton et al. 2006, Blood)); 13-15 g/dL (women) (Cohort of 17,030 community-dwelling adults 66 and older (Culleton et al. 2006, Blood)). Published reference intervals: 12-16 g/dL (women), 13-18 g/dL (men) (Cleveland Clinic). Lab reference interval: Men: 13.5-17.5 g/dL, Women: 12.0-15.5 g/dL. That is what a lab report flags against, not an optimal target.
Which blood test providers include Hemoglobin?
21 of the 21 blood testing panels we itemize marker by marker include Hemoglobin in their panels. This biomarker is widely available across major providers.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025